On Tuesday, an expert panel advising the Food and Drug Administration (FDA) on the use of MDMA, or ecstasy, in combination with talk therapy to treat post-traumatic stress disorder rejected the ...

An FDA advisory panel has recommended that the agency not approve the use of MDMA-assisted therapy as a treatment for PTSD. A U.S. Food and Drug Administration advisory committee voted on Tuesday ...

In a show of bipartisanship, 80 members of Congress from both sides of the aisle have united in letters urging President Joe Biden and the US Food and Drug Administration to further consider studies ...

VANCOUVER, BC, May 30, 2024 /PRNewswire/ - Numinus Wellness Inc. (NUMI:CA) ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative ...

When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...

Following a poor showing for Lykos Therapeutics’ MDMA candidate for post-traumatic stress disorder at a recent FDA advisory committee meeting, the other shoe has dropped. Friday, the FDA declined to ...

The FDA's decision on MDMA therapy for PTSD is imminent, impacting MindMed investors and the psychedelic medicine industry. An FDA advisory committee voted against approving MDMA therapy, causing ...

A panel of experts advising the Food and Drug Administration on the use of the psychedelic MDMA for post-traumatic stress disorder found on Tuesday that the available evidence fails to show that the ...

An F.D.A. advisory panel dealt a setback to those seeking treatment for PTSD, citing health risks of the illegal drug and study flaws. By Andrew Jacobs The Food and Drug Administration is weighing ...